📰 Chart Dynamix News
Chart Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chart Dynamix. Real-time updates on events, politics, business and more.
April 30, 2024
Data from Spherix Global Insights second annual EU IgAN patient chart audit indicates that even with the EMA approval of FILSPARITM (sparsentan),...
February 23, 2024
Although crowded, the RA market contains clear pathways for existing players and new entrants to navigate the evolving landscape and expand their market...
November 1, 2023
Exton, Pennsylvania, Nov. 01, 2023 (GLOBE NEWSWIRE) -- As U.S. ophthalmologists increasingly embrace a wider array of treatment options, the landscape of the diabetic macular edema (DME) market has begun
October 13, 2023
Exton, Pennsylvania, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The FDA's recent approvals of Calliditas' Tarpeyo (budesonide) and Travere's Filspari (sparsentan) to treat primary IgA nephropathy (IgAN) have
October 4, 2023
Exton, Pennsylvania, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Prior to the initial approval of Benlysta in 2011, systemic lupus erythematosus (SLE) patients and prescribers had limited options for the management
October 3, 2023
Analysis of 1,025 recently switched PsA patients reveals second- or later-line usage of IL-17, IL-23, and JAK inhibitors growing in popularity....
September 26, 2023
Exton, PA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Spherix Global Insights, a trusted leader in pharmaceutical market research, is delighted to announce the...